IHEARTMEDIA AND NETFLIX EXPAND VIDEO PODCAST DEAL WITH NEW SHOWS FROM MARTHA STEWART, KATE HUDSON, OLIVER HUDSON, AND LELE PONS. (PHOTO).

Image
   iHeartMedia and Netflix expand video podcast deal with new shows from Martha Stewart, Kate Hudson, Oliver Hudson, and Lele Pons  iHeartMedia and Netflix are expanding their video podcast partnership with a new slate of shows featuring Martha Stewart, Kate Hudson, Oliver Hudson, and Lele Pons, as the companies continue building out their shared podcast lineup on the streaming platform. Under the expanded agreement, select iHeartPodcasts will be adapted into video format for Netflix, including new episodes and portions of existing episode libraries. The rollout will take place over the coming months. The new additions include Suite 305 with Lele Pons, The Martha Stewart Podcast, and Sibling Revelry hosted by Kate Hudson and Oliver Hudson, which features conversations with sibling guests. The shows will join other iHeart titles already on Netflix’s video podcast slate. That lineup also includes programs such as The Breakfast Club, The Bobby Bones Show’s Bobbycast, and My ...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).